Aptinyx (APTX) Stock Forecast, Price Target & Predictions


OverviewOwnershipChart

APTX Stock Forecast


Aptinyx stock forecast is as follows: an average price target of $1.00 (represents a 941.67% upside from APTX’s last price of $0.10) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

APTX Price Target


The average price target for Aptinyx (APTX) is $1.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $1.00 to $1.00. This represents a potential 941.67% upside from APTX's last price of $0.10.

APTX Analyst Ratings


Buy

According to 3 Wall Street analysts, Aptinyx's rating consensus is 'Buy'. The analyst rating breakdown for APTX stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Aptinyx Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 26, 2022-H.C. Wainwright$1.00$0.40153.10%941.67%
Row per page
Go to

The latest Aptinyx stock forecast, released on Aug 26, 2022 by H.C. Wainwright company, set a price target of $1.00, which represents a 153.10% increase from the stock price at the time of the forecast ($0.40), and a 941.67% increase from APTX last price ($0.10).

Aptinyx Price Target by Period


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.10$0.10$0.10
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of Aptinyx stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aptinyx's last price of $0.10. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 15, 2022BMO CapitalOutperformOutperformHold
Aug 05, 2022SVB LeerinkOutperformOutperformHold
May 18, 2022Piper SandlerOverweightOverweightHold
Row per page
Go to

Aptinyx's last stock rating was published by BMO Capital on Aug 15, 2022. The company gave APTX a "Outperform" rating, the same as its previous rate.

Aptinyx Financial Forecast


Aptinyx Revenue Forecast

Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Mar 21Oct 20Jul 20Mar 20Oct 19Jul 19Mar 19Oct 18Jul 18
Revenue-------$1.00M--$818.00K--$890.00K--
Avg Forecast------$1.40M$1.00M$301.31K$508.15K$769.88K$936.00K$1.34M$801.00K$2.21M$3.47M
High Forecast------$1.40M$1.00M$301.31K$508.15K$769.88K$936.00K$1.34M$801.00K$2.21M$3.47M
Low Forecast------$1.40M$1.00M$301.31K$508.15K$769.88K$936.00K$1.34M$801.00K$2.21M$3.47M
# Analysts----------------
Surprise %-------1.00%--1.06%--1.11%--

Aptinyx's average Quarter revenue forecast for Mar 23 based on 0 analysts is $1.40M, with a low forecast of $1.40M, and a high forecast of $1.40M. APTX's average Quarter revenue forecast represents a 40.00% increase compared to the company's last Quarter revenue of $1.00M (Mar 21).

Aptinyx EBITDA Forecast

Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Mar 21Oct 20Jul 20Mar 20Oct 19Jul 19Mar 19Oct 18Jul 18
# Analysts----------------
EBITDA------$-20.00M$-13.81M--$-14.60M--$-16.59M--
Avg Forecast------$-840.00K$-13.81M$-13.17M$-12.86M$-13.69M$-14.68M$-15.71M$-14.75M$-19.92M$3.30M
High Forecast------$-840.00K$-11.05M$-10.54M$-10.29M$-10.95M$-11.74M$-12.57M$-11.80M$-15.94M$3.96M
Low Forecast------$-840.00K$-16.58M$-15.80M$-15.43M$-16.43M$-17.61M$-18.85M$-17.70M$-23.91M$2.64M
Surprise %------23.81%1.00%--1.07%--1.13%--

undefined analysts predict APTX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Aptinyx's previous annual EBITDA (undefined) of $NaN.

Aptinyx Net Income Forecast

Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Mar 21Oct 20Jul 20Mar 20Oct 19Jul 19Mar 19Oct 18Jul 18
# Analysts----------------
Net Income------$-21.81M$-14.23M--$-14.71M--$-16.71M--
Avg Forecast$104.38M$90.91M$106.75M$-5.42M$-3.39M$-15.57M$-12.87M$-14.23M$-13.29M$-12.96M$-13.79M$-14.79M$-15.86M$-14.85M$-20.09M$0.48
High Forecast$104.38M$90.91M$106.75M$-5.42M$-3.39M$-15.57M$-12.87M$-11.38M$-10.63M$-10.37M$-11.03M$-11.83M$-12.69M$-11.88M$-16.07M$0.48
Low Forecast$104.38M$90.91M$106.75M$-5.42M$-3.39M$-15.57M$-12.87M$-17.07M$-15.95M$-15.56M$-16.55M$-17.75M$-19.04M$-17.83M$-24.11M$0.48
Surprise %------1.70%1.00%--1.07%--1.13%--

Aptinyx's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. APTX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Aptinyx SG&A Forecast

Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Mar 21Oct 20Jul 20Mar 20Oct 19Jul 19Mar 19Oct 18Jul 18
# Analysts----------------
SG&A------$4.23M$4.98M--$4.90M--$5.72M--
Avg Forecast-------$4.98M$5.92M$4.94M$4.59M$4.52M$5.45M$5.09M$5.36M$3.30M
High Forecast-------$5.97M$7.10M$5.93M$5.51M$5.43M$6.55M$6.11M$6.43M$3.96M
Low Forecast-------$3.98M$4.74M$3.95M$3.67M$3.62M$4.36M$4.07M$4.29M$2.64M
Surprise %-------1.00%--1.07%--1.13%--

Aptinyx's average Quarter SG&A projection for Jul 23 is -, based on 0 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to APTX last annual SG&A of $4.23M (Mar 23).

Aptinyx EPS Forecast

Oct 24Jul 24Mar 24Dec 23Oct 23Jul 23Mar 23Mar 21Oct 20Jul 20Mar 20Oct 19Jul 19Mar 19Oct 18Jul 18
# Analysts----------------
EPS------$-0.32$-0.22--$-0.34--$-0.50--
Avg Forecast$1.54$1.34$1.58$-0.08$-0.05$-0.23$-0.19$-0.21$-0.30$-0.29$-0.33$-0.46$-0.52$-0.46$-0.48$-22.15M
High Forecast$1.54$1.34$1.58$-0.08$-0.05$-0.23$-0.19$-0.21$-0.30$-0.29$-0.33$-0.46$-0.52$-0.46$-0.48$-26.58M
Low Forecast$1.54$1.34$1.58$-0.08$-0.05$-0.23$-0.19$-0.21$-0.30$-0.29$-0.33$-0.46$-0.52$-0.46$-0.48$-17.72M
Surprise %------1.68%1.05%--1.03%--1.09%--

According to undefined Wall Street analysts, Aptinyx's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to APTX previous annual EPS of $NaN (undefined).

Aptinyx Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ADTXAditxt$0.49$160.0032553.06%-
APTXAptinyx$0.06$1.001566.67%Buy
RVPHReviva Pharmaceuticals$1.00$10.00900.00%Buy
SPROSpero Therapeutics$1.29$10.00675.19%Buy
CTMXCytomX Therapeutics$1.01$5.77471.29%Buy
ATXIAvenue Therapeutics$2.20$12.00445.45%Buy
NUVBNuvation Bio$2.29$6.75194.76%Buy
TILInstil Bio$27.63$78.25183.21%Hold
ASMBAssembly Biosciences$16.98$35.50109.07%Buy
ACHLAchilles Therapeutics$1.03$2.0094.17%Buy

APTX Forecast FAQ


Yes, according to 3 Wall Street analysts, Aptinyx (APTX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of APTX's total ratings.

Aptinyx (APTX) average price target is $1 with a range of $1 to $1, implying a 941.67% from its last price of $0.096. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for APTX stock, the company can go up by 941.67% (from the last price of $0.096 to the average price target of $1), up by 941.67% based on the highest stock price target, and up by 941.67% based on the lowest stock price target.

APTX's average twelve months analyst stock price target of $1 supports the claim that Aptinyx can reach $0 in the near future.

APTX's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $1.4M (high $1.4M, low $1.4M), average EBITDA is $-840K (high $-840K, low $-840K), average net income is $-37.244M (high $-37.244M, low $-37.244M), average SG&A $0 (high $0, low $0), and average EPS is $-0.55 (high $-0.55, low $-0.55).

In terms of the last quarterly report (Mar 2021), Aptinyx's revenue was $1M, beating the average analysts' forecast of $1M by 0%. The company's EBITDA was $-13.814M, beating the average prediction of $-13.814M by 0%. Aptinyx's net income was $-14.226M, beating the average estimation of $-14.226M by 0%. The company's SG&A was $4.98M, beating the average forecast of $4.98M by 0%. Lastly, the company's EPS was $-0.22, beating the average prediction of $-0.21 by 4.76%